Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Zymeworks Inc. - Common Stock
(NQ:
ZYME
)
24.94
+0.15 (+0.61%)
Streaming Delayed Price
Updated: 11:10 AM EDT, May 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
138,448
Open
24.61
Bid (Size)
24.92 (200)
Ask (Size)
24.99 (100)
Prev. Close
24.79
Today's Range
24.48 - 25.04
52wk Range
11.02 - 29.75
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock
May 14, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
May 13, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Performance
YTD
-6.3%
-6.3%
1 Month
-12.7%
-12.7%
3 Month
+3.4%
+3.4%
6 Month
-8.7%
-8.7%
1 Year
+122.3%
+122.3%
More News
Read More
Zymeworks Q1 Earnings Call Highlights
↗
May 09, 2026
Via
MarketBeat
Topics
Earnings
Zymeworks (NASDAQ:ZYME) Misses Q1 Estimates But August PDUFA Date for Zanidatamab Offers Key Regulatory Catalyst
↗
May 07, 2026
Via
Chartmill
Zymeworks Inc (NASDAQ:ZYME) Posts Wider Q4 Loss Despite Strategic Progress and Royalty Deal
↗
March 02, 2026
Via
Chartmill
Zymeworks (ZYME) Q1 2026 Earnings Transcript
↗
May 07, 2026
Via
The Motley Fool
Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 07, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million
↗
April 26, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026
April 21, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
April 16, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth
April 09, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Appoints Kristin Stafford as Chief Financial Officer
April 01, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
March 30, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
March 24, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.
↗
March 19, 2026
Via
The Motley Fool
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
March 18, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
March 17, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Wondering what's happening in today's pre-market session?
↗
March 09, 2026
Via
Chartmill
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
March 09, 2026
Via
Benzinga
Topics
Stocks
Zymeworks (ZYME) Q4 2025 Earnings Call Transcript
↗
March 02, 2026
Via
The Motley Fool
Topics
Earnings
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
March 02, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
March 02, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 02, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year
↗
February 22, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026
February 12, 2026
From
Zymeworks Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Zymeworks Inc. - Common Stock publicly traded?
Yes, Zymeworks Inc. - Common Stock is publicly traded.
What exchange does Zymeworks Inc. - Common Stock trade on?
Zymeworks Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Zymeworks Inc. - Common Stock?
The ticker symbol for Zymeworks Inc. - Common Stock is ZYME on the Nasdaq Stock Market
What is the current price of Zymeworks Inc. - Common Stock?
The current price of Zymeworks Inc. - Common Stock is 24.94
When was Zymeworks Inc. - Common Stock last traded?
The last trade of Zymeworks Inc. - Common Stock was at 05/28/26 11:10 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
